Debt to EBITDA ratio Analysis of aTyr Pharma Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of LIFE
Dec-23-0.0331Very Poor Debt to EBITDA | Dec-22-0.0201Very Poor Debt to EBITDA | Growth-65.04% |
Debt to EBITDA Analysis of aTyr Pharma Inc
| Debt to EBITDA Ratio of LIFE drastically fell by -65.04 % this year. |
| Debt to EBITDA Ratio with value of -0.0201 was highest in Year Dec-22 in last Five Years. |
| Debt to EBITDA Ratio with value of -0.427 was lowest in Year Dec-19 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of -0.0331 is Greater than Average Debt to EBITDA of -0.114 in last five years. |
Other Debt to EBITDA Related Info of LIFE that may interest you.
aTyr Pharma Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| LIFE | 2.0 | 1.93 | 3.63 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| No Significant Stability | |
FY - Historical Debt to EBITDA of aTyr Pharma Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| Debt to EBITDA | -0.0331 | -0.0201 | -0.0302 | -0.058 | -0.427 | -0.475 | -0.415 |
| Change | -65.04 % | 33.56 % | 47.56 % | 86.52 % | 10.08 % | -14.26 % | -148.03 % |
FY Chart of Debt to EBITDA of aTyr Pharma Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)